机译:继续探索二苯基磺酰胺支架作为聚集酶-1抑制的平台
Worldwide Medicinal Chemistry Pfizer Global Research and Development 200 CambridgePark Drive;
Worldwide Medicinal Chemistry Pfizer Global Research and Development 200 CambridgePark Drive;
Worldwide Medicinal Chemistry Pfizer Global Research and Development 200 CambridgePark Drive;
Worldwide Medicinal Chemistry Pfizer Global Research and Development 200 CambridgePark Drive;
Worldwide Medicinal Chemistry Pfizer Global Research and Development 200 CambridgePark Drive;
Astra Zeneca Research Center 35 Gatehouse Drive Waltham MA 02451 United States;
Abbott Laboratories 100 Abbott Park Road Abbott Park IL 60064 United States;
Worldwide Medicinal Chemistry Pfizer Global Research and Development 200 CambridgePark Drive;
Inflammation and Immunology Pfizer Global Research and Development 200 CambridgePark Drive;
Echelon Biosciences 675 Arapeen Drive Salt Lake City UT 84108 United States;
Inflammation and Immunology Pfizer Global Research and Development 200 CambridgePark Drive;
Inflammation and Immunology Pfizer Global Research and Development 200 CambridgePark Drive;
Inflammation and Immunology Pfizer Global Research and Development 200 CambridgePark Drive;
Worldwide Medicinal Chemistry Pfizer Global Research and Development 200 CambridgePark Drive;
Aggrecanase-1; Biphenylsulfonamide; MMP-13; Osteoarthritis;
机译:继续探索二苯基磺酰胺支架作为聚集酶-1抑制的平台
机译:继续探索三唑并吡啶支架作为p38 MAP激酶抑制的平台。
机译:继续探索三唑并吡啶支架作为p38 MAP激酶抑制的平台。
机译:跨平台软件可在不断变化的计算机平台上继续使用Brewer分光光度计进行长期观察:实现Model-View架构
机译:基于肽核酸的四链体形成寡核苷酸作为抑制蛋白相互作用的支架。
机译:基于模拟系列的支架:用于药物化学的新型分子支架的计算设计和探索
机译:金属蛋白酶的组织抑制剂(TIMP-1、2、3和4)对ADAMTS4(aggrecanase-1)的抑制作用